Molecular Nutrition

Inhibitory Effects of shRNA on Taurine Transporter of Rats Cardiac Myoblasts

  • YANG Qunhui ,
  • YANG Jiancheng ,
  • LIU Mei ,
  • WU Gaofeng ,
  • FENG Ying ,
  • HU Jianmin
Expand
  • College of Animal Science and Veterinary Medicine, Shenyang Agricultural University, Shenyang 110866, China

Received date: 2013-05-13

  Online published: 2013-10-27

Abstract

This experiment was conducted to investigate the inhibitory effects of short hairpin RNA (shRNA) on taurine transporter (TauT) of rats cardiac myoblasts. Three shRNAs expression vectors (shRNA1#, shRNA2# and shRNA3#) and one negative control shRNA expression vector were constructed to be targeted directly at TauT gene. Then the recombinant plasmids shRNA1#, shRNA2#, shRNA3# and shRNA-Neg were transfected into H9c2 cells with liposomes LipofectamineTM 2000, the cells were divided into control group (untransfected group), shRNA-Neg group (negative control group), and three transfected groups (shRNA1# group, shRNA2# group and shRNA3# group), each group contained three replicates. After transfection, TauT mRNA expression level was examined by using real-time quantitative PCR, and the state of cell proliferation was detected by methyl thiazolyl tetrazolium (MTT) assay. The results showed that compared with the negative control group and untransfected group, the shRNA1# plasmid significantly decreased the TauT mRNA expression level at 24 h after transfection (P<0.01), the shRNA2# plasmid significantly decreased the TauT mRNA expression level at 24, 48 and 72 h after transfection (P<0.01), and the shRNA3# plasmid significantly decreased the TauT mRNA expression level at 72 h after transfection (P<0.01). The MTT detected result showed that the cell proliferation in the transfected cells was not significantly affected by shRNAs plasmid compared with untransfected cells and negative control cells at 24, 48, 72 h (P>0.05). The present study indicates that the shRNA2# recombinant plasmid can effectively inhibit the expression of TauT gene and does not affect the proliferation of H9c2 cells at 72 h after transfection, which will be of benefit to the further study on the functions of TauT and taurine in cardiocytes metabolism.

Cite this article

YANG Qunhui , YANG Jiancheng , LIU Mei , WU Gaofeng , FENG Ying , HU Jianmin . Inhibitory Effects of shRNA on Taurine Transporter of Rats Cardiac Myoblasts[J]. Chinese Journal of Animal Nutrition, 2013 , 25(11) : 2643 -2648 . DOI: 10.3969/j.issn.1006-267x.2013.11.017

References

[1] LOMBARDINI J B.Taurine depletion in the intact animal stimulates in vitro phosphorylation of an 44-kDa protein present in the mitochondrial fraction of the rat heart[J].Journal of Molecular and Cellular Cardiology,1996,28(9):1957-1961.  

[2] ITO T,KIMURA Y,UOZUMI Y,et al.Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy[J].Journal of Molecular and Cellular Cardiology,2008,44(5):927-937.  

[3] YAMORI Y,NARA Y,IKEDA K,et al.Is taurine a preventive nutritional factor of cardiovascular diseases or just a biological marker of nutrition?[J].Advances in Experimental Medicine and Biology,1996,403:623-629.

[4] MIZUSHIMA S,MORIGUCHI E H,ISHIKAWA P,et al.Fish intake and cardiovascular risk among middle-aged Japanese in Japan and Brazil[J].Journal of Cardiovascular Risk,1997,4(3):191-199.  

[5] WÓJCIK O P,KOENIG K L,ZELENIUCH-JACQUOTTE A,et al.Serum taurine and risk of coronary heart disease:a prospective,nested case-control study[J].European Journal of Nutrition,2013,52(1):169-178.  

[6] ITO T,OISHI S,TAKAI M,et al.Cardiac and skeletal muscle abnormality in taurine transporter-knockout mice[J].Journal of Biomedical Science,2010,17(Suppl.1):S20.

[7] ALLARD M L,JEEJEEBHOY K N,SOLE M J.The management of conditioned nutritional requirements in heart failure[J].Heart Fail Reviews,2006,11(1):75-82.  

[8] EBY G,HALCOMB W W.Elimination of cardiac arrhythmias using oral taurine with L-arginine with case histories:hypothesis for nitric oxide stabilization of the sinus node[J].Medical Hypotheses,2006,67(5):1200-1204.  

[9] XU Y J,ARNEJA A S,TAPPIA P S,et al.The potential health benefits of taurine in cardiovascular disease[J].Experimental and Clinical Cardiology,2008,13(2):57-65.

[10] HUXTABLE R J.Physiological actions of taurine[J].Physiological Reviews,1992,72(1):101-163.

[11] PASANTES-MORALES H,HERNÁNDEZ-BENÍTEZ R.Taurine and brain development:trophic or cytoprotective actions?[J].Neurochemical Research,2010,35(12):1939-1943.  

[12] LIVAK K J,SCHMITTGEN T D.Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method[J].Methods,2001,25(4):402-408.  

[13] REYMOND I,BITOUN M,LEVILAIN O,et al.Regional expression and histological localization of cysteine sulfinate decarboxylase mRNA in the rat kidney[J].Journal of Histochemistry & Cytochemistry,2000,48(11):1461-1468.  

[14] SHI Y R,BU D F,QI Y F,et al.Dysfunction of myocardial taurine transport and effect of taurine supplement in rats with isoproterenol-induced myocardial injury[J].Acta Pharmacological Sinica,2002,23(10):910-918.

[15] HELLER-STILB B,VAN ROEYEN C,RASCHER K,et al.Disruption of the taurine transporter gene (taut) leads to retinal degeneration in mice[J].The Journal of the Federation of American Societies for Experimental Biology,2002,16(2):231-233.

[16] WARSKULAT U,FLÖGEL U,JACOBY C,et al.Taurine transporter knockout depletes muscle taurine levels and results in severe skeletal muscle impairment but leaves cardiac function uncompromised[J].The Journal of the Federation of American Societies for Experimental Biology,2004,18(3):577-579.

[17] FIRE A,XU S Q,MONTGOMERY M K,et al.Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans[J].Nature,1998,391(6669):806-811.  
Outlines

/